Thrivent Financial for Lutherans’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.57M | Buy |
92,999
+79,726
| +601% | +$2.2M | 0.01% | 1188 |
|
|
2025
Q1 | $376K | Sell |
13,273
-12,261
| -48% | -$347K | ﹤0.01% | 2167 |
|
|
2024
Q4 | $1.06M | Buy |
25,534
+3
| +0% | +$125 | ﹤0.01% | 1861 |
|
|
2024
Q3 | $1.71M | Sell |
25,531
-180
| -0.7% | -$12K | ﹤0.01% | 1554 |
|
|
2024
Q2 | $3.05M | Sell |
25,711
-73
| -0.3% | -$8.67K | 0.01% | 1119 |
|
|
2024
Q1 | $2.75M | Buy |
25,784
+11,992
| +87% | +$1.28M | 0.01% | 1189 |
|
|
2023
Q4 | $1.37M | Sell |
13,792
-126
| -0.9% | -$12.5K | ﹤0.01% | 1641 |
|
|
2023
Q3 | $1.44M | Sell |
13,918
-15,011
| -52% | -$1.55M | ﹤0.01% | 1526 |
|
|
2023
Q2 | $3.52M | Sell |
28,929
-1,042
| -3% | -$127K | 0.01% | 1003 |
|
|
2023
Q1 | $4.59M | Buy |
29,971
+12,359
| +70% | +$1.89M | 0.01% | 845 |
|
|
2022
Q4 | $3.16M | Buy |
17,612
+1,471
| +9% | +$264K | 0.01% | 984 |
|
|
2022
Q3 | $1.91M | Sell |
16,141
-314
| -2% | -$37.1K | 0.01% | 1248 |
|
|
2022
Q2 | $2.35M | Buy |
16,455
+178
| +1% | +$25.4K | 0.01% | 1140 |
|
|
2022
Q1 | $2.8M | Sell |
16,277
-9,248
| -36% | -$1.59M | 0.01% | 1132 |
|
|
2021
Q4 | $6.43M | Sell |
25,525
-19,483
| -43% | -$4.91M | 0.01% | 815 |
|
|
2021
Q3 | $17.3M | Sell |
45,008
-9,270
| -17% | -$3.57M | 0.04% | 508 |
|
|
2021
Q2 | $12.8M | Buy |
54,278
+1,516
| +3% | +$356K | 0.03% | 612 |
|
|
2021
Q1 | $6.91M | Buy |
52,762
+47,347
| +874% | +$6.2M | 0.02% | 789 |
|
|
2020
Q4 | $566K | Buy |
+5,415
| New | +$566K | ﹤0.01% | 2078 |
|